![Jim Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Murray
Corporate Officer/Principal chez
TSCAN THERAPEUTICS, INC.
Profil
Jim Murray is currently Chief Development Operations Officer at TScan Therapeutics, Inc. since 2024.
Formerly, Mr. Murray was Head-Clinical Operations at Rhythm Pharmaceuticals, Inc. from 2017 to 2019, Head-Clinical Operations at Merrimack Pharmaceuticals, Inc. from 2003 to 2017, and Head-Clinical Operations at Repertoire Immune Medicines, Inc. from 2019 to 2021.
Education includes an undergraduate degree from Boston College.
Postes actifs de Jim Murray
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2024 |
Anciens postes connus de Jim Murray
| Sociétés | Poste | Fin |
|---|---|---|
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Corporate Officer/Principal | 01/03/2021 |
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2019 |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | 01/03/2017 |
Formation de Jim Murray
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
